Araştırma
Eğitim
Çözümler
Oturum Aç
TR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Medicinal Chemistry,
Oncology,
IMED Biotech Unit,
Medicinal Chemistry, Oncology, IMED Biotech Unit
Elisabetta Chiarparin has not added Biography.
If you are Elisabetta Chiarparin and would like to personalize this page please email our Author Liaison for assistance.
Reducing the Lipophilicity of Perfluoroalkyl Groups by CF-F/CF-Me or CF/CH Exchange.
Journal of medicinal chemistry Dec, 2018 | Pubmed ID: 30411895
Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia.
Nature communications 12, 2018 | Pubmed ID: 30559424
Experimental free ligand conformations: a missing link in structure-based drug discovery.
Future medicinal chemistry Jan, 2019 | Pubmed ID: 30648432
AstraZeneca
Zhong Wang1,
Benjamin F. Jeffries1,
Hannah R. Felstead1,
Neil J. Wells1,
Elisabetta Chiarparin2,
Bruno Linclau1
1Chemistry, University of Southampton,
2Medicinal Chemistry, Oncology, IMED Biotech Unit, AstraZeneca
Gizlilik
Kullanım Şartları
İlkeler
Bize Ulaşın
KÜTÜPHANEYE TAVSİYE ET
JoVE HABER BÜLTENLERİ
JoVE Journal
Yöntem Koleksiyonları
JoVE Encyclopedia of Experiments
Arşiv
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Fakülte Kaynak Merkezi
Yazarlar
Kütüphaneciler
Erişim
JoVE Hakkında
Telif Hakkı © 2020 MyJove Corporation. Tüm hakları saklıdır